Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Leases (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Current Leases for 4 consecutive years, with $751000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 36.55% to $751000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $751000.0 through Dec 2025, up 36.55% year-over-year, with the annual reading at $751000.0 for FY2025, 36.55% up from the prior year.
  • Current Leases for Q4 2025 was $751000.0 at Orchestra BioMed Holdings, up from $696000.0 in the prior quarter.
  • The five-year high for Current Leases was $751000.0 in Q4 2025, with the low at $350000.0 in Q2 2024.
  • Average Current Leases over 4 years is $613230.8, with a median of $649000.0 recorded in 2023.
  • The sharpest move saw Current Leases tumbled 51.99% in 2024, then soared 83.43% in 2025.
  • Over 4 years, Current Leases stood at $697000.0 in 2022, then fell by 6.89% to $649000.0 in 2023, then fell by 15.25% to $550000.0 in 2024, then surged by 36.55% to $751000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $751000.0, $696000.0, and $642000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.